These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 10626050

  • 1. Antimalarial drugs for rheumatoid disease during pregnancy.
    Koren G.
    Can Fam Physician; 1999 Dec; 45():2869-70. PubMed ID: 10626050
    [Abstract] [Full Text] [Related]

  • 2. Pregnancy outcome following first trimester exposure to chloroquine.
    Levy M, Buskila D, Gladman DD, Urowitz MB, Koren G.
    Am J Perinatol; 1991 May; 8(3):174-8. PubMed ID: 2029276
    [Abstract] [Full Text] [Related]

  • 3. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C, Sperber K, Shapiro DL, Aronow WS, Chao CP, Ash JY.
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [Abstract] [Full Text] [Related]

  • 4. The role of anti-malarials in rheumatoid arthritis--the American experience.
    Khraishi MM, Singh G.
    Lupus; 1996 Jun; 5 Suppl 1():S41-4. PubMed ID: 8803910
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Ocular toxicity in children exposed in utero to antimalarial drugs: review of the literature.
    Osadchy A, Ratnapalan T, Koren G.
    J Rheumatol; 2011 Dec; 38(12):2504-8. PubMed ID: 22002012
    [Abstract] [Full Text] [Related]

  • 9. [Pharmacotherapy in pregnancy and lactation in rheumatic diseases].
    Anić B, Cikes N.
    Reumatizam; 2006 Dec; 53(2):55-8. PubMed ID: 17580555
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases].
    Falcão S, Mourão AF, Pimentão JB, Branco JC.
    Acta Reumatol Port; 2007 Dec; 32(4):323-31. PubMed ID: 18159198
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evidence for risk of cardiomyopathy with hydroxychloroquine.
    Sumpter MD, Tatro LS, Stoecker WV, Rader RK.
    Lupus; 2012 Dec; 21(14):1594-6. PubMed ID: 23036986
    [No Abstract] [Full Text] [Related]

  • 16. The use of antimalarials in combination with other disease modifying agents in rheumatoid arthritis--the French experience.
    Kahan A, Menkès CJ.
    Lupus; 1996 Jun; 5 Suppl 1():S45-9. PubMed ID: 8803911
    [Abstract] [Full Text] [Related]

  • 17. Dose-loading with hydroxychloroquine improves the rate of response in early, active rheumatoid arthritis: a randomized, double-blind six-week trial with eighteen-week extension.
    Furst DE, Lindsley H, Baethge B, Botstein GR, Caldwell J, Dietz F, Ettlinger R, Golden HE, McLaughlin GE, Moreland LW, Roberts WN, Rooney TW, Rothschild B, Sack M, Sebba AI, Weisman M, Welch KE, Yocum D.
    Arthritis Rheum; 1999 Feb; 42(2):357-65. PubMed ID: 10025931
    [Abstract] [Full Text] [Related]

  • 18. Disease modifying antirheumatic drugs: longterm safety issues.
    Capell HA.
    J Rheumatol Suppl; 2001 Jun; 62():10-5. PubMed ID: 11409152
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ocular toxicity of hydroxychloroquine.
    Tehrani R, Ostrowski RA, Hariman R, Jay WM.
    Semin Ophthalmol; 2008 Jun; 23(3):201-9. PubMed ID: 18432546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.